Shindoh et al.
SCHEME 5
(2R*,4S*)-6-Trifluoromethyl-4-(triisopropylsilyl)methyl-2-
phenyl-1,2,3,4-tetrahydroquinoline (trans-3aa). colorless viscous
1
oil; IR (neat) 1618, 1329, 1271, 1109, 1070 cm-1; H NMR (400
MHz, CDCl3) δ 7.38-7.22 (m, 7H), 6.53 (d, J ) 8.5 Hz, 1H),
4.62 (t, J ) 7.0 Hz, 1H), 4.38 (bs, 1H), 3.13-3.08 (m, 1H), 1.97
(dd, J ) 7.0, 4.1 Hz, 2H), 1.11-1.04 (m, 23H); 13C NMR (100
MHz, CDCl3) δ 146.0, 144.0, 128.8, 127.8, 127.6, 126.6, 125.7
(q, 3J(C,F) ) 3.3 Hz), 125.0 (q, 1J(C,F) ) 271.2 Hz), 124.1 (q, 3J(C,F)
2
) 4.1 Hz), 118.4 (q, J(C,F) ) 31.1 Hz), 113.2, 52.1, 37.4, 31.7,
19.1, 19.0, 18.9, 11.8; LRMS (APCI) m/z 448 (M+ + 1). Anal.
Calcd for C26H36F3NSi: C, 69.76; H, 8.11; N, 3.13. Found: C, 69.52;
H, 8.03; N, 3.00.
6-Trifluoromethyl-4-(triisopropylsilyl)methyl-2-phenylquino-
line (4aa). colorless plates; mp 104-106 °C; IR (KBr) 1591, 1470,
1
1312, 1119 cm-1; H NMR (400 MHz, CDCl3) δ 8.37 (s, 1H),
8.22 (d, J ) 8.8 Hz, 1H), 8.14 (d, J ) 7.1 Hz, 2H), 7.85 (d, J )
8.8 Hz, 1H), 7.75 (s, 1H), 7.56-7.46 (m, 3H), 2.75 (s, 2H),
1.19-1.12 (m, 3H), 1.10 (d, J ) 7.2 Hz, 18H); 13C NMR (100
MHz, CDCl3) δ 158.3, 150.8, 149.6, 139.4, 131.6, 129.7, 128.9,
127.6, 127.1 (q, J(C,F) ) 32.0 Hz), 125.9, 124.9 (q, J(C,F) ) 3.3
Hz), 124.4 (q, 1J(C,F) ) 272.8 Hz), 122.2 (q, 3J(C,F) ) 4.1 Hz), 119.5,
18.5, 16.5, 11.5; LRMS (APCI) m/z 444 (M+ + 1). Anal. Calcd
for C26H32F3NSi: C, 70.39; H, 7.27; N, 3.16. Found: C, 70.48; H,
7.24; N, 3.01.
from our synthesized quinolines 4ia-ka. When 4ia-ka were
reacted with 2.5 equiv of triphenylphosphine in refluxing
o-dichlorobenzene, indazolo[2,3-a]quinolines 13ia-ka were
obtained in 68-98% yield but no formation of benzo-δ-
carbolines 14 was observed (Scheme 5). The structure of 13
was fully assigned by DEPT techniques. In our case, steric
hindrance of the silylmethyl moiety of the C(4) position of 4
would suppress the approach of the nitrene group at the C(3)
position, leading to N-N bond formation preferred to result in
the production of indazolo[2,3-a]quinolines 13. Indazolo[2,3-
a]quinolines have been reported to show inhibitory effects on
reverse transcriptase.21
2
3
Typical Procedure for One-Pot Reaction of Tf2NH-Catalyzed
Povarov Reaction and DDQ-Mediated Oxidation (Table 4,
Entry 1). To a stirred solution of 2a (40.8 mg, 0.21 mmol) and 1a
(64.6 mg, 0.26 mmol) in 1,2-dichloroethane (0.2 mL) was added
Tf2NH (0.4 M solution in toluene, 77 µL, 31 µmol, 15 mol%) at
ambient temperature. The reaction mixture was stirred at 60 °C
for 3 h and then cooled to ambient temperature followed by addition
of 2,3-dichloro-5,6-dicyano-1,2-benzoquinone (DDQ, 94.0 mg, 0.41
mmol) in one portion. The brown reaction mixture was stirred at
the same temperature for 10 min (exothermic), diluted with CHCl3,
and filtered through pad of Celite. The organic layer was added
saturated aqueous solution of NaHCO3, and the aqueous phase was
extracted twice with CHCl3. Combined organic layers were washed
with saturated aqueous solution of NaHCO3, dried over MgSO4,
filtered, and concentrated in vacuo. The crude mixture was purified
by silica gel flash column chromatography (3: 2 CHCl3-hexane
with 0.5% NEt3) to afford 4aa (76.3 mg, 84%).
3-Bromo-5-(triisopropylsilyl)methylindazolo[2,3-a]quinolo-
ne (13ja). Quinoline 4ja (2.00 g, 4.00 mmol) and PPh3 (2.66 g,
10.1 mmol) were dissolved in 10 mL of o-dichlorobenzene and
heated to reflux for 10 h. The solvent was removed under high
vacuum, and the crude product was purified by silica gel column
chromatography (3:1 CHCl--hexane with 0.25% NEt3) to afford
13ja (1.83 g, 98%) as yellow solids: mp 149-151 °C; IR (KBr)
2941, 1632, 1545, 1356 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.81
(d, J ) 8.0 Hz, 1H), 8.16 (s, 1H), 7.98 (d, J ) 8.0 Hz, 1H), 7.87
(d, J ) 8.0 Hz, 1H), 7.82 (d, J ) 8.0 Hz, 1H), 7.64 (s, 1H), 7.52
(t, J ) 8.0 Hz, 1H), 7.19 (t, J ) 8.0 Hz, 1H), 2.53 (s, 2H),
1.16-1.11 (m, 3H), 1.01 (d, J ) 6.8 Hz, 18H); 13C NMR (100
MHz, CDCl3) δ 149.3, 133.4, 132.5, 132.1, 128.2, 126.5, 120.2,
119.8, 119.3 × 2, 116.2, 115.8, 114.4, 18.7, 15.7, 11.6; LRMS
(EI) m/z 466, 468 (M+, M+ + 2). Anal. Calcd for C25H31BrN2Si:
C, 64.23; H, 6.68; N, 5.99. Found: C, 63.89; H, 6.67; N, 5.98.
Conclusions
In summary, we have found that several acid catalysts, such
as Tf2NH, TfOH, and Lewis acids, activate two mechanistically
distinct reactions, such as the inverse-electron-demand hetero-
Diels-Alder reaction (Povarov reaction) and oxidative aroma-
tization, in a cascade reaction process. As a result, the reaction
of benzaldimines 1 and electron-rich olefins 2 in the presence
of the catalyst could afford substituted quinolines 4. As an
alternative way to access substituted quinolines, we found that
a one-pot reaction with the addition of DDQ as an oxidant would
be effective. The described approach in this paper would suggest
a rapid entry to synthesize substituted quinolines.
Experimental Section
Typical Procedure for Tf2NH-Catalyzed Cascade Povarov-
Hydrogen-Transfer Reaction (Table 1, Entry 5). To a stirred
solution of allyltriisopropylsilane (2a) (41.7 mg, 0.21 mmol) and
aldimine 1a (160 mg, 0.64 mmol) in 1,2-dichloroethane (0.9 mL)
was added Tf2NH (0.4 M solution in toluene, 52 µL, 21 µmol, 10
mol%) at ambient temperature. The reaction mixture was stirred at
60 °C for 24 h, diluted with CHCl3, and cooled to ambient
temperature. The mixture was quenched with satd NaHCO3, and
the aqueous phase was extracted twice with CHCl3. The combined
organic layers were dried over MgSO4, filtered, and concentrated
in vacuo. The crude mixture was purified by flash column
chromatography (2: 3 CHCl3-hexane with 0.5% NEt3, then CHCl3
with 0.5% NEt3) to afford 1,2,3,4-tetrahydroquinoline 3aa (46.4
mg, 49%, trans/cis ) 76:24) and quinoline 4aa (34.1 mg, 37%),
which was further purified by silica gel flash column chromatog-
raphy (1:8 AcOEt-hexane).
Acknowledgment. This work was financially supported by
a Grant-in-Aid for Scientific Research and Targeted Proteins
Research Program from the Ministry of Education, Culture,
Sports, Science and Technology, Japan.
Supporting Information Available: Experimental proce-
dures, full spectral data for all new compounds, and copies of
NMR spectra for all new compounds. This material is available
(21) Sharples, D.; Hajo´s, G.; Riedl, Z.; Csa´nyi, D.; Molna´r, J.; Szabo´, D.
Arch. Pharm. 2001, 334, 269–274.
JO8009243
7456 J. Org. Chem. Vol. 73, No. 19, 2008